药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levomenthol
Gemifloxacin
The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Sparfloxacin.
Levomenthol
Papaverine
The risk or severity of QTc prolongation can be increased when Papaverine is combined with Sparfloxacin.
Levomenthol
Dimenhydrinate
The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Sparfloxacin.
Levomenthol
Mesoridazine
The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Sparfloxacin.
Levomenthol
Levosimendan
The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Sparfloxacin.
Levomenthol
Ondansetron
The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Sparfloxacin.
Levomenthol
Granisetron
The risk or severity of QTc prolongation can be increased when Granisetron is combined with Sparfloxacin.
Levomenthol
Iron isomaltoside 1000
Iron isomaltoside 1000 can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferric maltol
Ferric maltol can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Sodium feredetate
Sodium feredetate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferrous fumarate
Ferrous fumarate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferrous succinate
Ferrous succinate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferrous gluconate
Ferrous gluconate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferrous chloride
Ferrous chloride can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferric hydroxide
Ferric hydroxide can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferrous sulfate anhydrous
Ferrous sulfate anhydrous can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Perflubutane
Perflubutane can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferric oxide
Ferric oxide can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Gleptoferron
Gleptoferron can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferrous bisglycinate
Ferrous bisglycinate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.